Business Due Diligence Services in Hyderabad

Reviewed by Devender Kumar Malhotra, Registered Valuer (Companies Act 2013) | Sapient Services Pvt. Ltd., New Delhi

A due diligence checklist built for a Delhi trading company won’t catch what matters on a Hyderabad pharma plant. Drug master files. CDSCO inspection history. Land tied to a TGIIC industrial allotment that may now fall under a state land-transformation policy nobody outside Telangana has heard of. None of that shows up in a generic financial-and-legal review.

The right due diligence scope depends heavily on the target’s sector. A pharma or API acquisition needs manufacturing and regulatory checks; an IT or GCC acquisition needs a deeper look at IP, contracts, and customer concentration. Sapient Services scopes each Hyderabad engagement around the sector the target actually sits in.

Request a Free Consultation → valuation@sapientservices.com | Call +91 9540162888

In Brief: Due diligence in Hyderabad covers financial, legal, tax, technical, and regulatory checks before you close a deal, fund a company, or extend credit. A pharma or API target adds manufacturing licences, CDSCO/USFDA filings, and GMP status to the list. An IT or GCC target adds platform and IP ownership checks. Buying industrial land now means checking whether the plot falls under Telangana’s HILTP land-transformation policy. Sapient Services scopes each engagement to the transaction — an indicative 2–3 weeks for a financial-only review, 4–8 weeks for a full multi-workstream engagement — drawing on Chartered Accountants and IBBI-registered valuers, with engineering and regulatory specialists brought in where the sector calls for it.

What Due Diligence Actually Means Here

Due diligence tests whether what’s in the data room holds up. It’s independent verification, not a read-through of whatever the seller hands over.

For a Hyderabad deal, that verification runs through state-specific channels as often as national ones: TGIIC (Telangana Industrial Infrastructure Corporation, the renamed TSIIC) allotments, CDSCO manufacturing licences, HMDA land-use approvals, and TG-iPASS clearances, alongside the Companies Act, 2013, FEMA, and the Income-tax Act, 2025, which came into force on 1 April 2026. Earlier tax years continue to be assessed under the 1961 Act.

Who Needs Due Diligence Services in Hyderabad?

• Pharma, API, and CDMO promoters raising private equity or selling a stake
• Banks and NBFCs sanctioning credit against a Genome Valley, Jeedimetla, or Patancheru manufacturing facility
• Foreign pharma or biotech companies entering Hyderabad through acquisition of an existing plant rather than a greenfield site
• GCC operators and IT services acquirers evaluating a HITEC City or Financial District target
• PE and VC funds backing Hyderabad startups, including T-Hub portfolio companies, ahead of a funding round
• Buyers and developers acquiring industrial or commercial land in TGIIC estates or along the ORR corridor
• Companies entering a joint venture with a Hyderabad-based pharma, CDMO, or IT partner

Our Process

1. Scoping call — what’s the deal, and which workstreams does it actually need
2. Confidentiality terms and engagement letter agreed before documents move
3. Document and site request — financials, CDSCO/USFDA filings, TGIIC/HMDA papers, contracts, depending on the sector
4. Verification — MCA/ROC searches, regulatory filing checks, and a facility visit if there’s a manufacturing plant involved
5. Risk ranking — findings sorted high/medium/low before the report goes final
6. Report and follow-through — findings by workstream, open items, and how they affect pricing or deal structure

Indicative timeline: a financial-only review typically takes 2–3 weeks. A full engagement with technical review for a pharma or CDMO facility usually runs 4–8 weeks. Actual duration depends on scope, document readiness, and how many entities or locations are involved.

Types of Due Diligence We Cover in Hyderabad

Financial Due Diligence

Financial due diligence checks audited financials against bank statements and GST filings, working capital trends, debt covenants, and whether reported earnings hold up under a buyer’s own assumptions rather than the seller’s.

Legal Due Diligence Coordination

Material contracts, litigation history, IP ownership, and corporate structure get reviewed against the Companies Act, 2013 and applicable sector rules. Where a point needs formal legal interpretation, that review is coordinated with qualified legal professionals rather than closed out internally.

Tax Due Diligence

Tax due diligence covers GST compliance, pending assessments, and transfer pricing exposure. For periods governed by the new regime, that means the Income-tax Act, 2025, effective 1 April 2026 — earlier tax years continue under the 1961 Act, and the two shouldn’t be treated as interchangeable.

Technical and Regulatory Due Diligence for Pharma, API & CDMO Facilities

This is where due diligence in Hyderabad looks nothing like Delhi or Mumbai. Depending on the products and markets involved, a pharma or API target’s technical scope can include manufacturing licence status, GMP certification, relevant regulatory dossiers, and any open USFDA or CDSCO inspection observations. Not every target carries the same filings — a domestic-only generics maker and an export-facing API plant don’t need the same regulatory checklist.

An unresolved inspection observation is a real risk a financial review alone won’t catch. Technical due diligence on the facility itself is handled by our engineering team, with CDSCO/USFDA filing interpretation brought in from regulatory-specific consultants where the assignment needs it.

Telangana’s Next-Gen Life Sciences Policy 2026–30, unveiled at Davos in January 2026, is also worth factoring in for any pharma or biotech transaction here. One change buyers should know about: R&D units can now be recognised as full industrial enterprises, which makes them eligible for incentives previously reserved for manufacturing facilities. If the target has applied for that reclassification, or is relying on incentives tied to it, that’s worth verifying rather than assuming.

IT and GCC Due Diligence

For HITEC City and Financial District targets, this covers platform and code ownership, client contract concentration, and any approvals or incentives the target holds under Telangana’s industrial policy framework. The terms attached to those approvals should be reviewed to check whether a change in ownership or control triggers fresh compliance or requires prior approval — that’s the real question, not whether an incentive exists.

Land and Industrial Property Due Diligence

For sites in Genome Valley, Jeedimetla, or Patancheru, this means reviewing title records, the original TGIIC or HMDA allotment documents, land-use and zoning permissions, building approvals, and encumbrance records — and flagging anything that needs further investigation. No due diligence review can guarantee an absence of undisclosed encumbrance; the job is to surface what the record shows and what it doesn’t.

There’s also a live policy question that didn’t exist two years ago. HILTP — the Hyderabad Industrial Lands Transformation Policy, approved under G.O. Ms. No. 27 on 22 November 2025 — covers 9,292 acres of industrial land across 21 parks within and near the Outer Ring Road, Jeedimetla and Patancheru included. It lets owners convert that land to residential, commercial, or mixed use, relocating the industry elsewhere, against a one-time Development Impact Fee based on the Sub-Registrar Office land value. TGIIC (the renamed TSIIC) is the nodal agency, and applications run through the TG-iPASS portal.

The fee structure and deadlines have moved more than once since launch, which is itself something a buyer should know rather than assume settled. The original framework set the fee at 30% of SRO value for plots on roads under 80 feet wide, and 50% for wider roads. Uptake has been slow — as of early August 2026, only around 193 applications covering roughly 450 of the 9,292 acres had come in, and the government pushed the application deadline back again, to 31 October 2026. The policy is also under legal challenge: the Telangana High Court has issued notices on a writ petition contesting it, with the matter listed for December 2026.

Fact-check flag: confirm the live fee percentage, deadline, and any concessions in force against the current TGIIC/G.O. No. 81 notification before quoting these to a client — this policy has changed multiple times in 2026 and is worth a fresh check at the point of engagement, not just before this page publishes.

Commercial Due Diligence

Market position, customer concentration, and whether growth assumptions hold up against the sector’s actual trajectory — the outside-in view that sits alongside the financial and legal workstreams.

What This Engagement Can Cover

Where the transaction needs it, Sapient Services can coordinate financial, technical, and other relevant due diligence workstreams into a single reporting structure, with specialist legal or regulatory input brought in where the assignment calls for it.

Pricing and Cost Guidance

Sapient Services scopes each Hyderabad engagement individually rather than quoting a flat rate before understanding the transaction. The factors below shape the estimate:

Get a Project Estimate — request a scoping call and Sapient Services can put together a scope-based estimate once the transaction is understood.

Common Mistakes to Avoid

• Treating a pharma facility’s regulatory filings as paperwork rather than a live risk — an open CDSCO or USFDA observation should be assessed directly, not taken at management’s word
• Not reading the full terms of a target’s Telangana industrial incentive approval before an ownership change, when those terms may attach conditions the new owner inherits
• Verifying company-level title but not the original TGIIC/HMDA allotment terms for an industrial plot — or assuming a HILTP deadline has passed when the government has already pushed it back twice this year
• Using one generalist reviewer across financial, technical, and regulatory workstreams on a complex CDMO or biotech deal, instead of sector-specific expertise for each
• Assuming a Hyderabad target’s compliance position matches a similarly sized Delhi or Mumbai company, when Telangana-specific approvals and incentives change the picture

Frequently Asked Questions

Q1: What does due diligence cost in Hyderabad?

A: Cost depends on the number of workstreams, sector complexity, and whether a site visit to a manufacturing facility is needed. A financial-only review for a straightforward company costs less than a multi-workstream engagement covering a pharma or CDMO facility.

Q2: How long does a due diligence engagement take in Hyderabad?

A: Indicative only — an engagement’s actual length depends on scope and how ready the documents are. A financial-only review typically takes 2–3 weeks; a full multi-workstream engagement, including technical review for a manufacturing facility, usually runs 4–8 weeks.

Q3: Is due diligence different for a pharma company than for an IT or GCC company in Hyderabad?

A: Yes. A pharma or API target adds manufacturing licence, GMP, and CDSCO/USFDA review on top of the standard financial and legal workstreams. An IT or GCC target instead needs platform and IP ownership checks and a review of any Telangana industrial incentive the target holds.

Q4: What documents should a Hyderabad company have ready before due diligence starts?

A: At minimum — audited financials, MCA/ROC filings, material contracts, and tax records. Pharma and API companies should also have manufacturing licences and CDSCO/USFDA filings ready; land-holding companies should have TGIIC or HMDA allotment papers.

Q5: How is due diligence different from a statutory audit?

A: An audit gives an opinion on whether the financial statements comply with accounting standards. Due diligence is investigative — it asks whether the deal makes sense and what risk you’re taking on. One doesn’t substitute for the other.

Q6: Can due diligence be done remotely for a Hyderabad target?

A: Financial, legal, and tax review can largely run on documents shared electronically. A site visit becomes worthwhile where plant condition, manufacturing capacity, or GMP status need independent verification rather than a document-based check.

Q7: Who typically requests due diligence services in Hyderabad?

A: Banks and NBFCs before sanctioning credit, PE and VC funds before an investment, corporates on both sides of an M&A transaction, foreign companies entering pharma or IT through acquisition, and buyers of industrial or commercial land.

Q8: Does HILTP affect due diligence on Hyderabad industrial property?

A: It can, if the property falls within the policy’s covered parks — Jeedimetla and Patancheru are among them. What to verify: whether the plot is inside the HILTP boundary, the current Development Impact Fee and deadline (both have shifted more than once since the policy launched in November 2025), and whether the seller has already filed a conversion application. As of August 2026, uptake has been low and the deadline has been extended to 31 October 2026 — treat any figure quoted to you as provisional, not final.

Q9: Is due diligence necessary for a startup raising its first funding round in Hyderabad?

A: It depends on the round and what the investor is asking for. Early-stage funding often calls for a focused review — financial records, legal standing, promoter background, basic compliance — rather than the full technical or regulatory depth a pharma or manufacturing deal requires.

Next Step

Before scoping a full engagement, start with a short call to work out which workstreams your deal actually needs. A straightforward IT acquisition and a CDMO facility purchase don’t call for the same review — and finding that out upfront is what keeps the engagement focused and the cost proportionate.

Sapient Services runs due diligence engagements across Hyderabad and India from our New Delhi office, bringing in sector and regulatory specialists where the transaction calls for it. Call +91 9540162888 or write to valuation@sapientservices.com to get started.